Arcus Biosciences, Inc. (RCUS)
24.42
+0.59
(+2.48%)
USD |
NYSE |
Oct 09, 16:00
24.42
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Price : 24.42 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 24.29 | 24.38 | 22.80 | 23.83 | 1.865M |
| Oct 07, 2026 | 24.22 | 24.85 | 23.90 | 24.52 | 1.601M |
| Oct 06, 2026 | 24.96 | 24.96 | 23.96 | 24.28 | 824849.0 |
| Oct 05, 2026 | 24.19 | 24.95 | 24.10 | 24.74 | 1.391M |
| Oct 02, 2026 | 25.48 | 25.58 | 24.09 | 24.44 | 1.042M |
| Oct 01, 2026 | 25.86 | 26.26 | 25.13 | 25.23 | 1.363M |
| Sep 30, 2026 | 26.18 | 26.35 | 25.56 | 25.83 | 1.362M |
| Sep 29, 2026 | 24.93 | 26.04 | 24.76 | 25.65 | 1.253M |
| Sep 28, 2026 | 24.85 | 25.50 | 24.35 | 25.01 | 1.249M |
| Sep 25, 2026 | 25.16 | 25.29 | 24.34 | 24.97 | 1.717M |
| Sep 24, 2026 | 26.20 | 26.49 | 24.42 | 25.06 | 2.038M |
| Sep 23, 2026 | 26.86 | 27.90 | 25.84 | 26.39 | 1.561M |
| Sep 22, 2026 | 26.34 | 27.11 | 26.04 | 26.87 | 1.385M |
| Sep 21, 2026 | 25.54 | 26.03 | 25.06 | 25.95 | 1.111M |
| Sep 18, 2026 | 25.74 | 25.74 | 25.02 | 25.24 | 2.897M |
| Sep 17, 2026 | 25.31 | 25.92 | 25.05 | 25.54 | 2.011M |
| Sep 16, 2026 | 24.79 | 25.28 | 24.18 | 24.65 | 2.296M |
| Sep 15, 2026 | 23.89 | 24.35 | 23.31 | 24.32 | 1.928M |
| Sep 14, 2026 | 24.59 | 24.99 | 24.02 | 24.07 | 1.721M |
| Sep 11, 2026 | 26.50 | 26.58 | 24.32 | 24.59 | 4.277M |
| Sep 10, 2026 | 28.02 | 28.46 | 25.91 | 26.15 | 2.391M |
| Sep 09, 2026 | 28.71 | 29.30 | 28.20 | 28.49 | 1.828M |
| Sep 08, 2026 | 29.21 | 29.50 | 28.79 | 29.06 | 1.364M |
| Sep 04, 2026 | 29.64 | 30.10 | 29.40 | 29.66 | 736982.0 |
| Sep 03, 2026 | 29.92 | 30.20 | 29.20 | 30.13 | 681695.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 110.47 |
| AVITA Medical, Inc. | 13.22 |
| Iovance Biotherapeutics, Inc. | 14.60 |
| Editas Medicine, Inc. | 2.895 |
| Recursion Pharmaceuticals, Inc. | 4.36 |
Price Related Metrics
| PS Ratio | 24.86 |
| PEG Ratio | -0.2699 |
| Price to Book Value | 6.684 |
| Earnings Yield | -15.99% |
| Market Cap | 3.101B |
| PEGY Ratio | -0.2699 |